Related Experiment Video

Updated: Jul 5, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.0K

MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport

Katharina Jonas1,2, Felix Prinz1,2, Manuela Ferracin3

  • 1Division of Oncology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.

Non-Coding RNA
|January 22, 2024
PubMed

Insights

MicroRNAs (miRNAs) like miR-4646-5p show promise in treating triple-negative breast cancer (TNBC). Higher miR-4646-5p levels correlate with better TNBC patient survival and inhibit tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are key gene regulators implicated in cancer development.
  • Triple-negative breast cancer (TNBC) requires novel therapeutic strategies.
  • The role of miR-4646-5p in breast cancer remains largely uncharacterized.

Purpose of the Study:

  • To investigate the function of miR-4646-5p in triple-negative breast cancer.
  • To determine the clinical significance of miR-4646-5p expression in TNBC patients.
  • To identify molecular targets and mechanisms underlying miR-4646-5p's role in TNBC.

Main Methods:

  • Analysis of miR-4646-5p expression in TNBC patient data.
  • In vitro functional assays (cell growth, proliferation, migration, tube formation).
  • Whole transcriptome analysis to identify downstream targets and pathways.
  • Validation of direct miRNA-target interaction (GRAMD1B).

Main Results:

  • Higher miR-4646-5p expression is associated with improved survival in TNBC patients.
  • Overexpression of miR-4646-5p suppressed TNBC cell growth, proliferation, and migration.
  • miR-4646-5p demonstrated anti-angiogenic potential by inhibiting endothelial cell tube formation.
  • miR-4646-5p downregulates oncogenic factors and directly targets GRAMD1B, a cholesterol transport protein.

Conclusions:

  • miR-4646-5p exhibits tumor-suppressive properties in triple-negative breast cancer.
  • miR-4646-5p may act as a therapeutic target for TNBC.
  • GRAMD1B is a potential mediator of miR-4646-5p's anti-cancer effects in TNBC.
Keywords:
GRAM domain-containing protein 1B (GRAMD1B)cholesterol transport proteinmicroRNA (miRNA)triple negative breast cancer (TNBC)

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.3K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K